We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Options & Director/PDMR Dealings

5 Oct 2018 17:50

RNS Number : 1988D
Quixant PLC
05 October 2018
 

Quixant plc

("Quixant" or the "Company")

 

Issue of Options & Director/PDMR Dealings

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms and monitors for gaming and slot machine applications, announces that it has granted 100,000 options ("Options") over ordinary shares of 0.1 pence in the capital of the Company ("Ordinary Shares") to Guy Millward, Chief Financial Officer of the Company (the "Grant").

 

The Options are exercisable at a price of 430 pence per Ordinary Share, being the closing mid-market price of an Ordinary Share on 28 September 2018, being the last trading day before Mr Millward took up his role on 1 October 2018 and are exercisable from the date of the release of the Company's audited accounts for the year ending 31 December 2020. The Options are exercisable subject to the growth of the diluted earnings per Ordinary Share (as set out in each of the audited accounts for the years ending 31 December 2018, 2019 and 2020) being equal to or greater than 10 per cent. in each financial year.

Following the Grant, there are a total of 437,268 Options outstanding, representing approximately 0.7 per cent. of the current issued share capital of the Company.

 

Further detail is set out in the PDMR disclosure table below.

 

For further information please contact:

Quixant plc

Tel: +44 (0) 1223 892696

Jon Jayal (Chief Executive Officer)

Guy Millward (Chief Financial Officer)

 

 

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44 (0) 20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (ECM)

 

Financial PR:

Tel: +44 (0) 20 8004 4217

Alma PR

 

John Coles / Susie Hudson

 

 

About Quixant

 

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

The information contained in this announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Guy Millward

 

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer / PDMR

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERSWQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Options over Ordinary Shares of £0.001

Identification code:

GB00B99PCP71

b)

Nature of the transaction:

Issue of options over Ordinary Shares

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

430 pence

100,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4 (c) above

e)

Date of the transaction:

1 October 2018

 

f)

Place of the transaction:

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFSDFMIFASELS
Date   Source Headline
27th Apr 20234:53 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement and Proposed Name Change
14th Apr 20237:00 amRNSExercise of options
4th Apr 20237:00 amRNSReport and Accounts and Notice of AGM
3rd Apr 20235:52 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of Options
21st Mar 20237:00 amRNSFinal Results
21st Feb 20237:00 amRNSNotice of Results and Investor Presentation
17th Jan 20238:15 amRNSExercise of options
16th Jan 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20238:59 amRNSHolding(s) in Company
3rd Nov 202212:09 pmRNSDirector Shareholding
26th Oct 20228:20 amRNSDirector Shareholding
14th Oct 20227:23 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
13th Sep 20227:00 amRNSAppointment of Non-Executive Directors
6th Sep 20227:00 amRNSInterim Results
1st Sep 20227:00 amRNSMass production order for gaming cabinet solutions
31st Aug 20227:00 amRNSNotice of Results and Presentations
14th Jul 20227:00 amRNSTrading Update and Notice of Results
9th May 20226:04 pmRNSGrant of Options
5th May 202211:55 amRNSResult of AGM
5th May 20227:00 amRNSAGM Statement
11th Apr 202211:37 amRNSReport and Accounts and Notice of AGM
5th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSNotice of Results and Presentations
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update and Notice of Results
29th Oct 20212:28 pmRNSGrant of Options
22nd Sep 20217:00 amRNSInterim Results
15th Sep 20217:00 amRNSInvestor Presentation
5th Aug 202111:16 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSTrading Update and Notice of Results
12th Jul 20213:02 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSAppointment of CFO
1st Jul 20217:00 amRNSDirector Shareholding
6th May 20215:12 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
19th Apr 20216:07 pmRNSHolding(s) in Company
19th Apr 20215:48 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSFinal Results
9th Apr 20214:40 pmRNSRescheduled Investor Presentation
9th Apr 20213:41 pmRNSAnnouncement of Final Results
6th Apr 20217:00 amRNSInvestor Presentation
26th Feb 20217:00 amRNSNotice of Results
12th Feb 20217:00 amRNSAppointment of Joint Broker
27th Jan 20217:00 amRNSTrading Update and Notice of Results
15th Jan 20217:00 amRNSAppointment of New Senior Independent NED
10th Dec 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.